Suppr超能文献

布鲁顿酪氨酸激酶在自身免疫中的作用及治疗意义。

The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.

作者信息

Crofford Leslie J, Nyhoff Lindsay E, Sheehan Jonathan H, Kendall Peggy L

机构信息

a Division of Rheumatology & Immunology, Department of Medicine , Vanderbilt University , Nashville , TN , USA.

b Department of Pathology, Microbiology & Immunology , Vanderbilt University , Nashville , TN , USA.

出版信息

Expert Rev Clin Immunol. 2016 Jul;12(7):763-73. doi: 10.1586/1744666X.2016.1152888. Epub 2016 Mar 4.

Abstract

Bruton's tyrosine kinase (BTK) mediates B cell signaling and is also present in innate immune cells but not T cells. BTK propagates B cell receptor (BCR) responses to antigen-engagement as well as to stimulation via CD40, toll-like receptors (TLRs), Fc receptors (FCRs) and chemokine receptors. Importantly, BTK can modulate signaling, acting as a "rheostat" rather than an "on-off" switch; thus, overexpression leads to autoimmunity while decreased levels improve autoimmune disease outcomes. Autoreactive B cells depend upon BTK for survival to a greater degree than normal B cells, reflected as loss of autoantibodies with maintenance of total antibody levels when BTK is absent. This review describes contributions of BTK to immune tolerance, including studies testing BTK-inhibitors for treatment of autoimmune diseases.

摘要

布鲁顿酪氨酸激酶(BTK)介导B细胞信号传导,也存在于固有免疫细胞中,但不存在于T细胞中。BTK将B细胞受体(BCR)对抗原结合以及通过CD40、Toll样受体(TLR)、Fc受体(FCR)和趋化因子受体的刺激反应进行信号传导。重要的是,BTK可以调节信号传导,起到“变阻器”而非“开关”的作用;因此,过度表达会导致自身免疫,而水平降低则会改善自身免疫性疾病的结果。自身反应性B细胞比正常B细胞在更大程度上依赖BTK来存活,这表现为当缺乏BTK时自身抗体丧失而总抗体水平维持。本综述描述了BTK对免疫耐受的作用,包括测试BTK抑制剂治疗自身免疫性疾病的研究。

相似文献

1
The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.
Expert Rev Clin Immunol. 2016 Jul;12(7):763-73. doi: 10.1586/1744666X.2016.1152888. Epub 2016 Mar 4.
2
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Front Immunol. 2019 Jan 30;10:95. doi: 10.3389/fimmu.2019.00095. eCollection 2019.
3
Enhanced Expression of Bruton's Tyrosine Kinase in B Cells Drives Systemic Autoimmunity by Disrupting T Cell Homeostasis.
J Immunol. 2016 Jul 1;197(1):58-67. doi: 10.4049/jimmunol.1600208. Epub 2016 May 25.
4
Bruton's Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease.
Drugs. 2021 Sep;81(14):1605-1626. doi: 10.1007/s40265-021-01592-0. Epub 2021 Oct 5.
5
Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.
Immunobiology. 2002 Oct;206(4):432-40. doi: 10.1078/0171-2985-00192.
6
Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
J Immunol. 2015 Jul 1;195(1):61-70. doi: 10.4049/jimmunol.1400803. Epub 2015 Jun 1.
10
The Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity.
Crit Rev Immunol. 2018;38(1):17-62. doi: 10.1615/CritRevImmunol.2018025184.

引用本文的文献

1
Rilzabrutinib for the Treatment of Immune Thrombocytopenia.
Eur J Haematol. 2025 Jul;115(1):4-15. doi: 10.1111/ejh.14425. Epub 2025 Apr 13.
4
Role of Lysyl Oxidase-Like Protein 3 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):33. doi: 10.1167/iovs.65.13.33.
5
The Immunomodulatory Mechanisms of BTK Inhibition in CLL and Beyond.
Cancers (Basel). 2024 Oct 23;16(21):3574. doi: 10.3390/cancers16213574.
6
Mechanisms of Resistance to Rituximab Used for the Treatment of Autoimmune Blistering Diseases.
Life (Basel). 2024 Sep 25;14(10):1223. doi: 10.3390/life14101223.
8
2025 update on clinical trials in immune thrombocytopenia.
Am J Hematol. 2024 Nov;99(11):2178-2190. doi: 10.1002/ajh.27448. Epub 2024 Aug 6.
9
Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia.
Blood Adv. 2024 Apr 9;8(7):1715-1724. doi: 10.1182/bloodadvances.2023012044.
10
Rilzabrutinib placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study.
Ther Adv Hematol. 2023 Oct 18;14:20406207231205431. doi: 10.1177/20406207231205431. eCollection 2023.

本文引用的文献

3
BTK Signaling in B Cell Differentiation and Autoimmunity.
Curr Top Microbiol Immunol. 2016;393:67-105. doi: 10.1007/82_2015_478.
5
Ibrutinib for the treatment of Waldenström macroglobulinemia.
Expert Rev Hematol. 2015 Oct;8(5):569-79. doi: 10.1586/17474086.2015.1061427. Epub 2015 Jul 2.
6
Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.
J Immunol. 2015 Jul 1;195(1):61-70. doi: 10.4049/jimmunol.1400803. Epub 2015 Jun 1.
9
Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis.
Cell Mol Immunol. 2015 Jul;12(4):493-504. doi: 10.1038/cmi.2015.37. Epub 2015 May 11.
10
CXCL13 antibody for the treatment of autoimmune disorders.
BMC Immunol. 2015 Feb 12;16(1):6. doi: 10.1186/s12865-015-0068-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验